Introduction
Recent years have seen a growing importance of administrative medical data for scientific purposes. Clinical research, as well as health service research, and health care economy increasingly demand medical data not only from surveys or clinical trails but also from data from entire populations in order to analyse and evaluate medical innovation or developments in a broader sense based upon real life settings. From this perspective it seems reasonable to address the topic of administrative medical data, its structure, availability and usefulness.
To avoid confusion about the term "administrative medical data" a short description will be given: The term depicts data which is has been established for administrative purposes in the field of health care provision. Typically it has been established for reimbursement of health care providers (e. g. doctors, nurses or hospitals), for usage in official statistics, or other administrative purposes. Thus, administrative medical data are secondary data, when used in scientific research contexts. Other frequently used or similar terms are "administrative data", "claims data", "reimbursement data". Administrative medical data may be contrasted to data especially established in medical surveys, in medical trails, or data derived directly from medical records.
There are numerous examples of administrative medical data from the international field.
Some well known examples are the Hospital Episodes Statistics (HES) from Great Britain, 1 the Veterans Affairs data collections, or the Medicare databases from the US.
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In the following article I will focus on administrative medical data of the statutory health insurance in Germany, from which health care sectors they derive. Their general structure and availability. An example form the field of health service research will be described, and future developments will be provided.
Administrative Medical Data of the Statutory Health in Germany
Since 125 Years medical care in Germany is financed using a health insurance based system.
Currently approximately 86 % of the population are insured within a statutory health insurance (GKV), while approximately 14 % are insured in a private health insurance (PKV) (Jacobs, et al. 2006 ). Health insurance is mostly regulated in Code of Social Law V (SGB V). it -compared with other health insurances -the largest database of this kind in Germany. (1) e. g. massages, ergo therapy, physical therapy, prosthesis (2) case specific, linkable on a anonymized individual level
In general the described administrative medical data contains the following information, which are usually stored in SQL-databases:
-type of disease (e. g. ICD)
-type of treatment (e. g. procedural classification)
These data may be linked to additionally administrative data related to the health insured.
Therefore information about e. g. survival of the individual, place of residence, status of insurance, or end of insurance may be used for further scientific purposes.
As a consequence it seems possible and tempting to perform individual longitudinal analyses using data from (nearly) all medical sectors and considering all contacts to the medical system, addressing long time follow up endpoints. It is thus of high interest for research analyses.
Accessibility of Data:
It may be seen as a serious drawback that the described data is currently only available to health insurances, as well as to some researchers performing research in cooperation with these health insurances (e. g. AOK-Bundesverband et al. 2007 , Bramesfeld et al. 2007 , Geyer 2008 , Grobe et al. 2008 , Heller et al. 2004 , Heller 2006 , Müller and Braun 2006 , Schubert et al. 2007 , Swart and Heller 2007 , Swart and Ihle 2005 .
This limited data access is due to the fact of data privacy protection of individual insured as well as of the involved institutions (e. g. hospitals). However, there are (at least) two regulations which could make these data available to the scientific community in the future: § 303 SGB V Data Transparency: According to this act administrative medical data from all health insurances should be pooled in a data trust centre. These data should be made available to health insurers, health authorities, and several other defined user groups, e. g. independent scientific organisations. However, the level of aggregation in which the data may be available to the public is not fixed. Thus, data may be distributed on the individual level, or on some aggregated level. Additionally it is still unclear how expensive using these data would be for external researches. How the data will be compiled, distributed, and to which expense it will be provided is still discussed within the bodies of Germany's joint self administrated health system. § 137 SGB V Quality of Medical Care: In the latest health care reform this act was renewed in March 2007. According to this reform a quality agency shall be assigned to develop and provide "inter sectoral" comprehensive quality assurance. This agency is now allowed to use administrative medical data. As a consequence it might be interesting to focus on this agency when thinking about using administrative medical data in future years. Which institution will be the quality agency is still unclear, as the pan-European tendering procedure for this agency is still in progress.
Aspects of Data Quality
Is the needed information present: Administrative medical data has been established primarily for other reasons. Thus, interesting information might not be, or might be insufficiently present. As an example consider social status of an individual or individual quality of life measures. To illustrate this further: there has been a long going discussion, whether administrative medical data provides sufficient information to perform risk adjusted analyses when comparing hospitals performance measurements, e. g. 30-day survival after admission of acute myocardial infarction. While older analyses have questioned sufficient risk adjusted analyses using administrative medical data, recent works form Great Britain and the US showed similar performance of administrative medical data compared to clinical data or clinical register data when predicting survival after hospital admission due to several tracerdiagnoses or procedures (Aylin et al. 2007 , Pine et al. 2007 ). Although it should be noted that good prediction is only a poor indicator for good risk adjustment (Heller and Schnell 2007) .
Data-Validity:
Administrative medical data is secondary data. But validation of this data usually refers to it's primary purpose. E. g. reimbursement data from the hospital sector is usually checked by health insurances addressing the accuracy of the invoice using plausibility checks (internal validity) as well as external validity by audits comparing transferred administrative medical data with clinical data from medical records. Several contents are usually not important for reimbursement. Time of coded procedures, or admission diagnoses and are therefore neither checked nor corrected. Nevertheless such information may be of great importance in other analytic perspectives. Performing medical administrative data analyses for different purposes should therefore be aware of data validity of every data field used.
To my knowledge there has been no comprehensive validity study from either health sector in Germany examining the validity of administrative medical data from a medical / scientific perspective. It seems reasonable to perform such an external validation study in the near future before using administrative medical data on a wider basis.
In general, data validity in administrative medical data, may be expected to increase with longer duration of administrative establishment of data transfer. Thus administrative medical data from hospital care or pharmaceutical prescriptions are usually considered to be valid and reliable (regular data transfer since 1998). Data from the ambulatory sector, where data transfer started in 2004, has been questioned recently (Gerste and Gutschmidt 2006 , Giersiepen et al. 2007 , Trautner et al. 2005 . Another aspect might be, whether the interesting information is linked to reimbursement. E. g. Type and amount of prescribed pharmaceuticals is directly linked to reimbursement and is thus considered to be valid. Documentation of (primary and secondary) diagnoses in the hospital sector has dramatically increased during the implementation of DRG-related reimbursement of hospitals, whereas diagnosis from the ambulatory sector are not directly related to reimbursement and have been shown to be invalid to a considerable extent (Gerste and Gutschmidt 2006 , Giersiepen et al. 2007 , Trautner et al. 2005 . However, related to the morbidity orientated risk structure compensation (Morbititäts-Orientierter-Risikostrukturausgleich) this might change dramatically within the nearest future.
Completeness of data:
Usually this kind of data is considered to be highly complete in the sense that virtually all cases a present in the data. Several other systems rely on administrative medical data by using them a data source (e. g. DRG-based statistics of Hospital diagnoses from the federal statistical office (Spindler 2008) ), or using it as a gold standard (e. g.
completeness of documented quality data by the federal office for quality assurance (Veith et al. 2008) ).
For several years there is a working group addressing administrative medical data's contents and possible usage (Working Group Secondary Data Analyses, Arbeitsgruppe Sekundärdatenanalyse, AGENS) in Germany. Some years ago a handbook using administrative medical data has been published which provides a good and detailed overview of administrative medical data in Germany (Swart and Ihle 2005) . A shorter more up-to-date description may be find in (Swart and Heller 2007) . Additionally, guidelines addressing "Good Practice Secondary Data Analysis" have been developed by this group (Swart et al. 2005 ). Meanwhile they have been adapted in cooperation with several scientific societies, and have been adopted by funding Agencies recently. 4
A Health service research example using administrative medical data
The volume outcome relationship of very low birth weight infants (VLBWs) might serve as an example of health service research using administrative medical data. In Germany, the These analyses have meanwhile been extended to spatial simulation analyses for different minimum provider volumes. In a first step distances from patients places of residence to hospitals providing care were calculated. In a second step it was simulated how these distances changed after introducing minimum provider values. Additionally, changes in survival after introduction different minimum provider volumes were estimated (Heller 2009 ).
These and similar analyses are currently being used for the counselling referring to this topic at the Federal Joint Committee.
Discussion and Conclusion
-Administrative medical data provides detailed information about medical care provision for large samples or even entire populations.
-Existing diseases, medical therapy as well as health outcomes, are available in these data.
-Especially the possibility to perform individual longitudinal analyses using individual identifiers seems to draw special interest from researchers with clinical economic and social research interests.
In the current article I have aimed to described or at least mention the most important administrative medical data collections in Germany, addressed issues like data validity, completeness and (future) accessibility of administrative medical data. Additionally I have provided an up-to-date example referring to health service research based referring to very low birth weight infants based upon administrative administrative medical data.
-It should be kept in mind, however, that health and illness also exists outside the official medical system within the lay system (Borgetto and Trojan 2007) . The onset of a disease might occur long before the contact to a doctor and self administered treatments, e. g. using ubiquitous available over the counter drugs, are known to cure numerous diseases without any contact to the official medical system. Incidence or prevalence studies may be difficult to justify under this restriction.
From this perspective administrative medical data of Statutory Health Insurances tells only part of the story. Thus, depending on the research question, it may seem wise to enrich administrative medical data with other data sources, when addressing research questions.
